FOCINVEZ FDA approval date

The FDA approved FOCINVEZ on 22 Aug 2023.

FDA approval date
22 Aug 2023

Drug identity has not yet been verified against registry records

Also recorded as FOSAPREPITANT DIMEGLUMINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-08-22DayFOCINVEZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216686", "applicant_as_listed_by_fda": "STERISCIENCE", "brand_names": ["FOCINVEZ"], "active_ingredients": ["FOSAPREPITANT DIMEGLUMINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230822", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026